McKesson (NYSE:MCK) raised its fiscal 2027 adjusted earnings outlook after reporting higher second-quarter revenue and profit, supported by prescription volumes, specialty distribution and demand for medication access services. The company now expects adjusted earnings of $45.60 to $46.40 per diluted share for the fiscal year, up from its previous forecast of $44.20 to $45.00. The […]

Sanmina (NASDAQ:SANM) forecast fiscal 2027 revenue of $17.5 billion to $19.5 billion as it begins shipping AMD’s Helios accelerated-compute systems and prepares to ramp additional cloud and artificial intelligence programs. The outlook followed a fiscal fourth quarter in which revenue rose 84% from a year earlier to $3.86 billion. The company’s results exceeded its guidance, […]